Loh Chin Siew
Keine laufenden Positionen mehr
Karriereverlauf von Loh Chin Siew
Ehemalige bekannte Positionen von Loh Chin Siew
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ProTherapeutics Pte Ltd.
 ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Direktor/Vorstandsmitglied | - | - |
| Singapore Economic Development Board | Corporate Officer/Principal | - | - |
Bio*One Capital Pte Ltd.
 Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Private Equity Investor | - | - |
Ausbildung von Loh Chin Siew
| INSEAD | Masters Business Admin |
| University of Bristol | Undergraduate Degree |
Statistik
International
| Singapur | 4 |
| Frankreich | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Finance |
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |
| Singapore Economic Development Board | Government |
- Börse
- Insiders
- Loh Chin Siew
- Erfahrung